x
14 December, 2019
Facebook Twitter Youtube Instagram E-mail
Fundación Grupo Efecto Positivo

Main menu

Skip to content
  • About us
    • Goals
    • Board
    • Funding
    • Partners
  • Projects
    • Access to Medicines Program
    • Influencing Public Opinion
    • Capacity Building
    • Research
    • FTA Monitoring
    • Public Debate Forums
  • Library
    • The power of communities against monopolies
    • Eu-Mercosur Bi-Regional Association Agreement
    • FGEP’s main national and international circulation print, radio and TV publications – January/June 2017
  • Contact us
  • Oportunities
  • Subscribe to our newsletter

Category: RedLAM

RedLAM in Geneva: A week of actions against the Corporate Power and to reclaim Peoples Sovereignty 

Between October 12th and 19th, RedLAM is in Geneva participating of the “Week of Peoples”, a wake up call...
Access to Medicines, Direct Action, Intellectual Property, RedLAM

Argentina: elimination of the Ministry of Health threatens PLHIV lives.

From Fundación GEP, we express our harsh condemnation, and warn the population about the measure announced today by the...
Argentina, HIV, Ministry of Health, Public Health, RedLAM

International Congress on Access to Medicines and Human Rights’ Full Schedule

Access to Medicines, Argentina, Capacity Building, Direct Action, Health Safeguards, Intellectual Property, Medicines, Public Health, RedLAM

International Congress on Access to Medicines, Medical Technologies and Human Rights

Buenos Aires, Argentina – 16, 17 and 18 November 2016 15 years of the Doha Declaration on TRIPS and Public Health:...
Access to Medicines, Argentina, Direct Action, Health Safeguards, Intellectual Property, Medicines, Public Health, RedLAM

Big Pharma’s court cases in Brazil & Argentina threaten national laws considered important public health safeguards in the UN HLP report

September 15th 2016 – Press release Fundación Grupo Efecto Positivo (FGEP) – Associação Brasileira Interdisciplinar de AIDS (ABIA) –...
Access to Medicines, Argentina, Health Safeguards, HIV, Intellectual Property, Medicines, Public Health, RedLAM

FGEP and other Latin American organizations requested a Thematic Hearing at the Inter-American Commission on Human Rights

Por: Julia Varela   GEP Foundation (FGEP), along with more than 20 other civil society organizations from different countries...
Advocacy, Direct Action, Hepatitis C, HIV, Medicines, Public Health, RedLAM

International Forum: Access to HIV and Hepatitis C Medicines

Citizens, organizations and experts analyzed the current challenges to hep C and HIV medicine’s access at the International Forum...
Access to Medicines, Capacity Building, Hepatitis C, HIV, Intellectual Property, RedLAM
Fundación GEP dijo #FUERAG20 FMI
https://www.youtube.com/watch?v=mopMoJZ15Sc
Biblioteca
  • Observatorio de Acceso a Medicamentos para VIH y Hepatitis C en Argentina
  • La actualidad de las negociaciones entre la Unión Europea y el MERCOSUR: una peligrosa forma de ‘volver al mundo’
  • Estudio de impacto del acuerdo Mercosur-Unión Europea
  • El PCT pone en riesgo la salud pública
  • Informe: la Hepatitis C en Argentina – Julio 2017 (junto a Fundación Soberanía Sanitaria)
  • Cuadernillo 1: Fundación Grupo Efecto Positivo
  • Cuadernillo 2: Mitos y verdades en torno al VIH
  • Cuadernillo 3: La sociedad civil y las políticas públicas
  • Cuadernillo 4: ¿Cómo evitamos los monopolios y el alto precio?
  • Cuadernillo 5: Oposiciones a patentes, salvaguarda de la salud pública
  • Cuadernillo 6: Nueva ley de VIH, Hepatitis virales e ITS.
  • Cuadernillo 7: El impacto de los tratados de libre comercio
  • INGLÉS: The power of communities against monopolies
  • Especial Audiovisual #AccesoAMedicamentos
  • Especial Audiovisual #TestimoniosHepatitisC
Categories
  • 909090 Strategy
  • Access to Medicines
  • Advocacy
  • Argentina
  • Capacity Building
  • Direct Action
  • Health Safeguards
  • Hepatitis C
  • HIV
  • Intellectual Property
  • Kaletra
  • Medicines
  • Ministry of Health
  • Patent opposition
  • Public Health
  • RedLAM
  • Sin categoría
  • Sofosbuvir
  • UNAIDS
© Fundación Grupo Efecto Positivo